Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe in Chronic Hepatitis C
NCT02126137Phase 1Unknown
- Sponsor
- Pontificia Universidad Católica de Chile
- Start
- Oct 2013
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ezetimibe in hepatitis C (HCV), sponsored by Pontificia Universidad Católica de Chile. Primary endpoint: HCV plasma viral load at 12 weeks. Status: unknown.
02
Drugs
ezetimibe
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02126137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02126137.